0001648841-18-000001.txt : 20180907 0001648841-18-000001.hdr.sgml : 20180907 20180907162641 ACCESSION NUMBER: 0001648841-18-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180907 DATE AS OF CHANGE: 20180907 EFFECTIVENESS DATE: 20180907 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Epharmix, Inc. CENTRAL INDEX KEY: 0001648841 IRS NUMBER: 473940610 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-320889 FILM NUMBER: 181060437 BUSINESS ADDRESS: STREET 1: 4240 DUNCAN AVE. CITY: ST. LOUIS STATE: MO ZIP: 6310 BUSINESS PHONE: 925-899-2669 MAIL ADDRESS: STREET 1: 4240 DUNCAN AVE. CITY: ST. LOUIS STATE: MO ZIP: 6310 D 1 primary_doc.xml X0708 D LIVE 0001648841 Epharmix, Inc. 4220 Duncan Ave Suite 201 ST. LOUIS MO MISSOURI 63110 925-899-2669 DELAWARE None None Corporation true 2015 Blake Marggraff 4220 Duncan Ave Suite 201 St. Louis MO MISSOURI 63110 Executive Officer Director Promoter Avik Som 4220 Duncan Ave Suite 201 St. Louis MO MISSOURI 63110 Executive Officer Director Promoter Mark Bakken 4220 Duncan Ave Suite 201 St. Louis MO MISSOURI 63110 Director Max Bricklin 4220 Duncan Ave St. Louis MO MISSOURI 63110 Director Other Technology Decline to Disclose 06b false 2018-05-30 false true false 0 2996666 1875000 1121666 false 6 0 0 0 false Epharmix, Inc. /s/ Blake Marggraff Blake Marggraff CEO 2018-09-06